Mesoblast Limited (MESO)

Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of $1.57 billion. The enterprise value is $1.66 billion.

Market Cap	1.57B
Enterprise Value	1.66B

Important Dates

The last earnings date was Wednesday, February 26, 2025, after market close.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Mesoblast has 1.15 billion shares outstanding. The number of shares has increased by 31.98% in one year.

Current Share Class	n/a
Shares Outstanding	1.15B
Shares Change (YoY)	+31.98%
Shares Change (QoQ)	+1.81%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	719.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	276.42
Forward PS	n/a
PB Ratio	3.40
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	292.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.27.

Current Ratio	0.96
Quick Ratio	0.56
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.43

Financial Efficiency

Return on equity (ROE) is -21.31% and return on invested capital (ROIC) is -5.27%.

Return on Equity (ROE)	-21.31%
Return on Assets (ROA)	-4.85%
Return on Invested Capital (ROIC)	-5.27%
Return on Capital Employed (ROCE)	-8.85%
Revenue Per Employee	$77,671
Profits Per Employee	-$1.42M
Employee Count	73
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, Mesoblast has paid $123,000 in taxes.

Income Tax	123,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +139.42% in the last 52 weeks. The beta is 2.34, so Mesoblast's price volatility has been higher than the market average.

Beta (5Y)	2.34
52-Week Price Change	+139.42%
50-Day Moving Average	16.19
200-Day Moving Average	11.09
Relative Strength Index (RSI)	29.95
Average Volume (20 Days)	305,852

Short Selling Information

Short Interest	2.65M
Short Previous Month	2.48M
Short % of Shares Out	1.58%
Short % of Float	n/a
Short Ratio (days to cover)	6.69

Income Statement

In the last 12 months, Mesoblast had revenue of $5.67 million and -$103.35 million in losses. Loss per share was -$0.09.

Revenue	5.67M
Gross Profit	-20.99M
Operating Income	-51.37M
Pretax Income	-73.25M
Net Income	-103.35M
EBITDA	-49.43M
EBIT	-51.37M
Loss Per Share	-$0.09

Balance Sheet

The company has $38.03 million in cash and $126.11 million in debt, giving a net cash position of -$88.08 million or -$0.08 per share.

Cash & Cash Equivalents	38.03M
Total Debt	126.11M
Net Cash	-88.08M
Net Cash Per Share	-$0.08
Equity (Book Value)	461.26M
Book Value Per Share	0.40
Working Capital	-3.07M

Cash Flow

In the last 12 months, operating cash flow was -$42.54 million and capital expenditures -$183,000, giving a free cash flow of -$42.72 million.

Operating Cash Flow	-42.54M
Capital Expenditures	-183,000
Free Cash Flow	-42.72M
FCF Per Share	-$0.04

Margins

Gross Margin	n/a
Operating Margin	-906.03%
Pretax Margin	-1,820.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.98%
Shareholder Yield	-31.98%
Earnings Yield	-6.59%
FCF Yield	-2.73%

Analyst Forecast

The average price target for Mesoblast is $18.00, which is 46.64% higher than the current price. The consensus rating is "Buy".

Price Target	$18.00
Price Target Difference	46.64%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	162.87%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 10, 2024. It was a reverse split with a ratio of 0.5:1.

Last Split Date	Jan 10, 2024
Split Type	Reverse
Split Ratio	0.5:1

Scores

Mesoblast has an Altman Z-Score of 0.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.04
Piotroski F-Score	3